Literature DB >> 22488745

Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience.

Laurent Milot1, Masoom Haider, Lynette Foster, Cailtin McGregor, Calvin Law.   

Abstract

PURPOSE: To investigate enhancement of hepatic lesions with gadofosveset trisodium (Gdfos) (Ablavar) (blood pool agent) compared with the extracellular gadolinium contrast agent (EcGd) gadobutrol (Gadovist).
MATERIALS AND METHODS: The prospective study was approved by the Institutional Research Ethics Board with informed consent. Twelve patients underwent magnetic resonance imaging (MRI) with EcGd followed by MRI with Gdfos. For each agent qualitative analysis described the pattern of enhancement and quantitative analysis was performed using lesion-to-liver contrast-to-noise (CNR) ratio. Paired and unpaired Student's t-test used.
RESULTS: Twelve hemangiomas, four metastases, one cyst, two focal nodular hyperplasia (FNH), and three adenomas were found. Cyst, FNH, adenomas, and hemangiomas demonstrated the classic pattern of enhancement with both agents. Hemangiomas demonstrated retention of contrast with both agents and their CNR was not statistically different (P > 0.05). Metastases demonstrated retention of contrast on delayed phase with EcGd. Retention of contrast was not seen in metastases with Gdfos. CNR of metastases with Gdfos was statistically lower than CNR of metastases with EcGd (P = 0.005). CNR of hemangiomata and metastases on delayed phase were significantly different (P = 0.0008) with Gdfos, but similar with EcGd (P = 0.4).
CONCLUSION: Hemangiomas accumulate Gdfos on delayed phase and metastases do not, a key additional differentiating feature. Liver imaging with Gdfos may improve characterization of liver lesions.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488745     DOI: 10.1002/jmri.23650

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

Review 1.  Extracardiac applications of MR blood pool contrast agent in children.

Authors:  Shannon G Farmakis; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2014-11-19

Review 2.  Venous malformations: clinical diagnosis and treatment.

Authors:  Sasan Behravesh; Wayne Yakes; Nikhil Gupta; Sailendra Naidu; Brian W Chong; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

Review 3.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

4.  Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.

Authors:  Peter Bannas; Candice A Bookwalter; Tim Ziemlewicz; Utaroh Motosugi; Alejandro Munoz Del Rio; Theodora A Potretzke; Scott K Nagle; Scott B Reeder
Journal:  Eur Radiol       Date:  2016-04-30       Impact factor: 5.315

5.  Gadofosveset-enhanced magnetic resonance imaging as a problem-solving tool for diagnosing colorectal liver metastases: a case report.

Authors:  Helen Cheung; Paul Karanicolas; Natalie Coburn; Calvin Law; Laurent Milot
Journal:  Quant Imaging Med Surg       Date:  2018-04

6.  Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo.

Authors:  Owen C Richardson; Octavia Bane; Marietta L J Scott; Steven F Tanner; John C Waterton; Steven P Sourbron; Timothy J Carroll; David L Buckley
Journal:  Magn Reson Med       Date:  2014-02-11       Impact factor: 4.668

7.  Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.

Authors:  Helen M C Cheung; Paul J Karanicolas; Eugene Hsieh; Natalie Coburn; Tishan Maraj; Jin K Kim; Howaida Elhakim; Masoom A Haider; Calvin Law; Laurent Milot
Journal:  Eur Radiol       Date:  2018-02-23       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.